Dr. Gentry Wilkerson, Associate Professor, Department of Emergency Medicine, has partnered with Drs. Joel Chua and Shivakumar Narayanan as principal investigators of three clinical trials assessing Regeneron’s monoclonal antibody cocktail for the treatment of COVID-19 in hospitalized and ambulatory patients as well as for prophylaxis to prevent infection in people exposed to COVID. The studies were approved to enroll as of the beginning of October.
Preliminary data on the study of this drug in nonhospitalized patients was released September 29.
Blog Archives
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012